Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis Review

Tzouvelekis, Argyrios, Toonkel, Rebecca, Karampitsakos, Theodoros et al. (2018). Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis . Frontiers in Medicine, 5 10.3389/fmed.2018.00142

Open Access International Collaboration

cited authors

  • Tzouvelekis, Argyrios; Toonkel, Rebecca; Karampitsakos, Theodoros; Medapalli, Kantha; Ninou, Ioanna; Aidinis, Vasilis; Bouros, Demosthenes; Glassberg, Marilyn K

sustainable development goals

authors

publication date

  • May 15, 2018

published in

keywords

  • ACUTE LUNG INJURY
  • CLINICALLY IMPORTANT DIFFERENCE
  • CONVERTING ENZYME 2
  • FORCED VITAL CAPACITY
  • General & Internal Medicine
  • ISCHEMIC CARDIOMYOPATHY
  • Life Sciences & Biomedicine
  • MARROW PROGENITOR CELLS
  • MYOCARDIAL-INFARCTION
  • Medicine, General & Internal
  • RANDOMIZED-TRIAL
  • STROMAL CELLS
  • Science & Technology
  • TYROSINE KINASE INHIBITOR
  • efficacy
  • idiopathic pulmonary fibrosis
  • mesenchymal stem cells
  • safety
  • treatment

Digital Object Identifier (DOI)

volume

  • 5